» Articles » PMID: 37569462

Dysregulations of Key Regulators of Angiogenesis and Inflammation in Abdominal Aortic Aneurysm

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Aug 12
PMID 37569462
Authors
Affiliations
Soon will be listed here.
Abstract

Abdominal aortic aneurysm (AAA) is a chronic vascular disease caused by localized weakening and broadening of the abdominal aorta. AAA is a clearly underdiagnosed disease and is burdened with a high mortality rate (65-85%) from AAA rupture. Studies indicate that abnormal regulation of angiogenesis and inflammation contributes to progression and onset of this disease; however, dysregulations in the molecular pathways associated with this disease are not yet fully explained. Therefore, in our study, we aimed to identify dysregulations in the key regulators of angiogenesis and inflammation in patients with AAA in peripheral blood mononuclear cells (using qPCR) and plasma samples (using ELISA). Expression levels of , , , , , and and plasma levels of TGF-alpha, TGF-beta 1, VEGF-A, and VEGF-C were found to be significantly altered in the AAA group compared to the control subjects without AAA. Associations between analyzed factors and risk factors or biochemical parameters were also explored. Any of the analyzed factors was associated with the size of the aneurysm. The presented study identified dysregulations in key angiogenesis- and inflammation-related factors potentially involved in AAA formation, giving new insight into the molecular pathways involved in the development of this disease and providing candidates for biomarkers that could serve as diagnostic or therapeutic targets.

Citing Articles

Molecular Insights into Cardiovascular Disease: Unraveling Pathways for Diagnosis and Treatment.

Yamanouchi D Int J Mol Sci. 2025; 26(5).

PMID: 40076691 PMC: 11900358. DOI: 10.3390/ijms26052067.


Atractylenolide-I prevents abdominal aortic aneurysm formation through inhibiting inflammation.

Chen S, Liu X, Zhou X, Lin W, Liu M, Ma H Front Immunol. 2025; 16:1486072.

PMID: 39958337 PMC: 11825332. DOI: 10.3389/fimmu.2025.1486072.


Thymidine Phosphorylase Promotes Abdominal Aortic Aneurysm via VSMC Modulation and Matrix Remodeling in Mice and Humans.

Hong L, Yue H, Cai D, DeHart A, Toloza-Alvarez G, Du L Cardiovasc Ther. 2025; 2024:1129181.

PMID: 39742002 PMC: 11669429. DOI: 10.1155/cdr/1129181.


Affinity-Enriched Plasma Proteomics for Biomarker Discovery in Abdominal Aortic Aneurysms.

Palstrom N, Nielsen K, Campbell A, Soerensen M, Rasmussen L, Lindholt J Proteomes. 2024; 12(4).

PMID: 39728917 PMC: 11678615. DOI: 10.3390/proteomes12040037.


Vascular Endothelial Growth Factor and the Pathogenesis of Intracranial Aneurysms: A Systematic Review on the Missing Link in a Complex Pathway.

Nisson P, Lawton M, Cisneros O, Maeda T, Gonzalez N, Frosen J J Am Heart Assoc. 2024; 13(23):e035638.

PMID: 39575766 PMC: 11681557. DOI: 10.1161/JAHA.124.035638.


References
1.
Tingting T, Wenjing F, Qian Z, Hengquan W, Simin Z, Zhisheng J . The TGF-β pathway plays a key role in aortic aneurysms. Clin Chim Acta. 2019; 501:222-228. DOI: 10.1016/j.cca.2019.10.042. View

2.
Golledge J . Abdominal aortic aneurysm: update on pathogenesis and medical treatments. Nat Rev Cardiol. 2018; 16(4):225-242. DOI: 10.1038/s41569-018-0114-9. View

3.
Wan L, Huang J, Ni H, Yu G . Screening key genes for abdominal aortic aneurysm based on gene expression omnibus dataset. BMC Cardiovasc Disord. 2018; 18(1):34. PMC: 5812227. DOI: 10.1186/s12872-018-0766-8. View

4.
Zalewski D, Ruszel K, Stepniewski A, Galkowski D, Bogucki J, Komsta L . Dysregulation of microRNA Modulatory Network in Abdominal Aortic Aneurysm. J Clin Med. 2020; 9(6). PMC: 7355415. DOI: 10.3390/jcm9061974. View

5.
Li X, Zhao G, Zhang J, Duan Z, Xin S . Prevalence and trends of the abdominal aortic aneurysms epidemic in general population--a meta-analysis. PLoS One. 2013; 8(12):e81260. PMC: 3846841. DOI: 10.1371/journal.pone.0081260. View